Phase 3 COPD Trial, Recruiting NCT06785337 Sponsor: Beni-Suef University Condition: COPD
Back to Copd

Phase 3 COPD Trial, Recruiting

NCT06785337
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have a flare-up of COPD (a lung disease that makes breathing difficult) along with breathing failure, and whose heart scan (echocardiogram) shows high blood pressure in the arteries of the lungs (with a specific pressure reading above 20 mmHg)

Who may not be able to join:

  • People whose left side of the heart is pumping very poorly, as the study medication could make their condition worse by causing fluid to build up in the lungs
  • People who are pregnant
  • People who have had an allergic reaction or sensitivity to nitroglycerin (a medication used to widen blood vessels)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Beni-Suef University
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 October 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Change in pulmonary functions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov